Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Controlled Release - Volume 280, 28 June 2018, Pages 113-123

Jahidur Rashid, Ahmad Alobaida, Taslim A. Al-Hilal, Samia Hammouda, Ivan F. McMurtry, Eva Nozik-Grayck, Kurt R. Stenmark, Fakhrul Ahsan,